Literature DB >> 2337495

Phaeochromocytoma and catecholamine induced cardiomyopathy presenting as heart failure.

S H Sardesai1, A J Mourant, Y Sivathandon, R Farrow, D O Gibbons.   

Abstract

Phaeochromocytoma is rare and usually presents as paroxysmal or sustained hypertension; none the less, it can also cause severe acute pulmonary oedema in normotensive individuals. Six patients with phaeochromocytoma presenting in Cornwall and West Devon between 1982 and 1986 are described. Five of them died of pulmonary oedema within 24 hours of the onset of symptoms. At necropsy all five had normal sized hearts and in the four hearts examined by histology there was evidence of catecholamine induced heart disease in the form of focal myocardial necrosis. The sixth patient presented with arterial spasms and pulmonary oedema. Surgical removal of the causative tumour was successful in this patient.

Entities:  

Mesh:

Year:  1990        PMID: 2337495      PMCID: PMC1024438          DOI: 10.1136/hrt.63.4.234

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  19 in total

1.  L-Norepinephrine myocarditis.

Authors:  J E SZAKACS; A CANNON
Journal:  Am J Clin Pathol       Date:  1958-11       Impact factor: 2.493

2.  Catecholamine cardiomyopathy.

Authors:  S Bloom
Journal:  N Engl J Med       Date:  1987-10-01       Impact factor: 91.245

Review 3.  Cardiovascular injury induced by sympathetic catecholamines.

Authors:  J I Haft
Journal:  Prog Cardiovasc Dis       Date:  1974 Jul-Aug       Impact factor: 8.194

4.  Pheochromocytoma without hypertension presenting as cardiomyopathy.

Authors:  G Baker; N H Zeller; S Weitzner; J K Leach
Journal:  Am Heart J       Date:  1972-05       Impact factor: 4.749

5.  Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma.

Authors:  J Imperato-McGinley; T Gautier; K Ehlers; M A Zullo; D S Goldstein; E D Vaughan
Journal:  N Engl J Med       Date:  1987-03-26       Impact factor: 91.245

6.  Focal myocarditis associated with pheochromocytoma.

Authors:  P D Van Vliet; H B Burchell; J L Titus
Journal:  N Engl J Med       Date:  1966-05-19       Impact factor: 91.245

Review 7.  Catecholamine cardiotoxicity.

Authors:  G Rona
Journal:  J Mol Cell Cardiol       Date:  1985-04       Impact factor: 5.000

8.  Role of free radicals in catecholamine-induced cardiomyopathy.

Authors:  P K Singal; N Kapur; K S Dhillon; R E Beamish; N S Dhalla
Journal:  Can J Physiol Pharmacol       Date:  1982-11       Impact factor: 2.273

9.  Cardiomyopathy in a rat model of pheochromocytoma. Morphological and functional alterations.

Authors:  J S Rosenbaum; M E Billingham; R Ginsburg; G Tsujimoto; K G Lurie; B B Hoffman
Journal:  Am J Cardiovasc Pathol       Date:  1988

10.  Calcium as mediator of isoproterenol-induced myocardial necrosis.

Authors:  S Bloom; D L Davis
Journal:  Am J Pathol       Date:  1972-12       Impact factor: 4.307

View more
  39 in total

Review 1.  Pheochromocytoma as an endocrine emergency.

Authors:  Frederieke M Brouwers; Jacques W M Lenders; Graeme Eisenhofer; Karel Pacak
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

2.  A woman with recurrent cardiac ischemia without coronary artery disease.

Authors:  Ronald C W Ma; Gabriel W K Yip; Chun Chung Chow; Clive S Cockram
Journal:  CMAJ       Date:  2007-01-16       Impact factor: 8.262

3.  Pheochromocytoma multisystem crisis successfully treated by emergency surgery: report of a case.

Authors:  Naotaka Uchida; Kiyosuke Ishiguro; Takako Suda; Motonobu Nishimura
Journal:  Surg Today       Date:  2010-09-25       Impact factor: 2.549

4.  Phaeochromocytoma found on cardiovascular magnetic resonance in a patient presenting with acute myocarditis: an unusual association.

Authors:  Sophia Khattak; Iain Sim; Luke Dancy; Benjamin Whitelaw; Dan Sado
Journal:  BMJ Case Rep       Date:  2018-06-08

5.  [Treatment of an uncommon case of a cardiogenic shock : Simultaneous use of a VA-ECMO and an Impella-CP®].

Authors:  H Haake; K Grün-Himmelmann; U Kania; F Trudzinski; P M Lepper; J Vom Dahl
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-08-02       Impact factor: 0.840

6.  Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.

Authors:  J Malcom; O Arnold; Jonathan G Howlett; Anique Ducharme; Justin A Ezekowitz; Martin J Gardner; Nadia Giannetti; Haissam Haddad; George A Heckman; Debra Isaac; Philip Jong; Peter Liu; Elizabeth Mann; Robert S McKelvie; Gordon W Moe; Anna M Svendsen; Ross T Tsuyuki; Kelly O'Halloran; Heather J Ross; Errol J Sequeira; Michel White
Journal:  Can J Cardiol       Date:  2008-01       Impact factor: 5.223

7.  Opposing cardiac effects of autoantibody activation of β-adrenergic and M2 muscarinic receptors in cardiac-related diseases.

Authors:  Stavros Stavrakis; David C Kem; Eugene Patterson; Pedro Lozano; Shijun Huang; Bela Szabo; Madeleine W Cunningham; Ralph Lazzara; Xichun Yu
Journal:  Int J Cardiol       Date:  2010-01-06       Impact factor: 4.164

8.  Biochemical detection of phaeochromocytoma: should we still be measuring urinary HMMA?

Authors:  R T Peaston; L C Lai
Journal:  J Clin Pathol       Date:  1993-08       Impact factor: 3.411

9.  Recurrent catecholamine-induced cardiomyopathy in a patient with a pheochromocytoma.

Authors:  Se Yong Jang; Dong Heon Yang; Sang Hyuk Lee; Jae Hee Kim; Sun Hee Park; Hun Sik Park; Yongkeun Cho; Shung Chull Chae; Jae Eun Jun; Wee Hyun Park
Journal:  Korean Circ J       Date:  2009-06-30       Impact factor: 3.243

10.  Cardiovascular magnetic resonance and PET-CT of left atrial paraganglioma.

Authors:  Anderanik Tomasian; Chi Lai; Stefan Ruehm; Mayil S Krishnam
Journal:  J Cardiovasc Magn Reson       Date:  2010-01-04       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.